<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2751
  </number>
  <updateDate>
   2023-01-11T13:48:38Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:38Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-22
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 70 (Thursday, April 22, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. DEAN:H.R. 2751.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H2107]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsju00
    </systemCode>
    <name>
     Judiciary Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsju10
      </systemCode>
      <name>
       Constitution and Limited Government Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-10-19T19:42:24Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-22T13:05:40Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif18
      </systemCode>
      <name>
       Environment, Manufacturing, and Critical Materials Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-23T17:17:00Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-22T13:05:35Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     PFAS Accountability Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     1334
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-04-22
     </actionDate>
     <text>
      Read twice and referred to the Committee on Environment and Public Works.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-10-19
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsju10
      </systemCode>
      <name>
       Constitution and Limited Government Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-23
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif18
      </systemCode>
      <name>
       Environment, Manufacturing, and Critical Materials Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Environment and Climate Change.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-22
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsju00
      </systemCode>
      <name>
       Judiciary Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-22
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-22
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-22
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     D000631
    </bioguideId>
    <fullName>
     Rep. Dean, Madeleine [D-PA-4]
    </fullName>
    <firstName>
     Madeleine
    </firstName>
    <lastName>
     Dean
    </lastName>
    <party>
     D
    </party>
    <state>
     PA
    </state>
    <district>
     4
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     K000380
    </bioguideId>
    <fullName>
     Rep. Kildee, Daniel T. [D-MI-5]
    </fullName>
    <firstName>
     Daniel
    </firstName>
    <lastName>
     Kildee
    </lastName>
    <party>
     D
    </party>
    <state>
     MI
    </state>
    <middleName>
     T.
    </middleName>
    <district>
     5
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000481
    </bioguideId>
    <fullName>
     Rep. Tlaib, Rashida [D-MI-13]
    </fullName>
    <firstName>
     Rashida
    </firstName>
    <lastName>
     Tlaib
    </lastName>
    <party>
     D
    </party>
    <state>
     MI
    </state>
    <district>
     13
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     N000002
    </bioguideId>
    <fullName>
     Rep. Nadler, Jerrold [D-NY-10]
    </fullName>
    <firstName>
     JERROLD
    </firstName>
    <lastName>
     NADLER
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     10
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001296
    </bioguideId>
    <fullName>
     Rep. Boyle, Brendan F. [D-PA-2]
    </fullName>
    <firstName>
     Brendan
    </firstName>
    <lastName>
     Boyle
    </lastName>
    <party>
     D
    </party>
    <state>
     PA
    </state>
    <middleName>
     F.
    </middleName>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001159
    </bioguideId>
    <fullName>
     Rep. Strickland, Marilyn [D-WA-10]
    </fullName>
    <firstName>
     Marilyn
    </firstName>
    <lastName>
     Strickland
    </lastName>
    <party>
     D
    </party>
    <state>
     WA
    </state>
    <district>
     10
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000624
    </bioguideId>
    <fullName>
     Rep. Dingell, Debbie [D-MI-12]
    </fullName>
    <firstName>
     Debbie
    </firstName>
    <lastName>
     Dingell
    </lastName>
    <party>
     D
    </party>
    <state>
     MI
    </state>
    <district>
     12
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     N000192
    </bioguideId>
    <fullName>
     Rep. Newman, Marie [D-IL-3]
    </fullName>
    <firstName>
     Marie
    </firstName>
    <lastName>
     Newman
    </lastName>
    <party>
     D
    </party>
    <state>
     IL
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001185
    </bioguideId>
    <fullName>
     Rep. Maloney, Sean Patrick [D-NY-18]
    </fullName>
    <firstName>
     Sean
    </firstName>
    <lastName>
     Maloney
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <middleName>
     Patrick
    </middleName>
    <district>
     18
    </district>
    <sponsorshipDate>
     2021-04-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000306
    </bioguideId>
    <fullName>
     Rep. Jones, Mondaire [D-NY-17]
    </fullName>
    <firstName>
     Mondaire
    </firstName>
    <lastName>
     Jones
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     17
    </district>
    <sponsorshipDate>
     2021-05-07
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Environmental Protection
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Blood and blood diseases
     </name>
    </item>
    <item>
     <name>
      Civil actions and liability
     </name>
    </item>
    <item>
     <name>
      Environmental assessment, monitoring, research
     </name>
    </item>
    <item>
     <name>
      Environmental health
     </name>
    </item>
    <item>
     <name>
      Federal district courts
     </name>
    </item>
    <item>
     <name>
      Hazardous wastes and toxic substances
     </name>
    </item>
    <item>
     <name>
      Health care costs and insurance
     </name>
    </item>
    <item>
     <name>
      Health care coverage and access
     </name>
    </item>
    <item>
     <name>
      Health promotion and preventive care
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Medical research
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      Pollution liability
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Environmental Protection
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-22
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2022-01-21T15:38:34Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;PFAS Accountability Act of 2021&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill provides a cause of action under the Toxic Substances Control Act for individuals or classes of individuals who were significantly exposed to perfluoroalkyl or polyfluoroalkyl substances, commonly referred to as PFAS. These substances are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing.&lt;/p&gt; &lt;p&gt;Specifically, the bill provides a cause of action those who were significantly exposed to PFAS (or have reasonable grounds to believe they were exposed) against persons who engaged in any portion of a manufacturing process that created the PFAS and foresaw (or reasonably should have foreseen) the creation or use of PFAS would result in human exposure.&lt;/p&gt; &lt;p&gt;The bill authorizes a court to award medical monitoring to claimants if (1) they have been significantly exposed to PFAS, (2) they have an increased risk of developing a disease associated with such exposure, (3) the increased risk provides a reasonable basis to conclude that periodic diagnostic medical examinations is necessary, and (4) the medical examinations are effective in detecting a disease associated with PFAS exposure.&lt;/p&gt; &lt;p&gt;The bill establishes a presumption of significant exposure to PFAS if the claimant (1) provides medical results proving the presence of PFAS in the body, or (2) demonstrates the defendant's manufacturing process created the PFAS to which the claimant was exposed and the PFAS were released into one or more areas where the claimant would have been exposed for at least one year.&lt;br&gt; &lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   PFAS Accountability Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     PFAS Accountability Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Toxic Substances Control Act to codify a Federal cause of action and a type of remedy available for individuals significantly exposed to per- and polyfluoroalkyl substances, to encourage research and accountability for irresponsible discharge of those substances, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     PFAS Accountability Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-22T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2751ih/xml/BILLS-117hr2751ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-10-19
   </actionDate>
   <text>
    Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-10-19
Constitution and Limited Government Subcommittee
hsju10
1
House committee actions
Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
Committee
2021-04-23
Environment, Manufacturing, and Critical Materials Subcommittee
hsif18
1
House committee actions
Referred to the Subcommittee on Environment and Climate Change.
Committee
H11100
2021-04-22
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-22
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-22
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-22
9
Library of Congress
Introduced in House
IntroReferral
2021-04-22T13:05:40Z
Referred to
House
Judiciary Committee
2021-10-19T19:42:24Z
Referred to
Constitution and Limited Government Subcommittee
hsju10
hsju00
Standing
2021-04-22T13:05:35Z
Referred to
House
Energy and Commerce Committee
2021-04-23T17:17:00Z
Referred to
Environment, Manufacturing, and Critical Materials Subcommittee
hsif18
hsif00
Standing
K000380
5
Daniel
Rep. Kildee, Daniel T. [D-MI-5]
Kildee
T.
D
2021-04-22
MI
T000481
13
Rashida
Rep. Tlaib, Rashida [D-MI-13]
Tlaib
D
2021-04-22
MI
N000002
10
JERROLD
Rep. Nadler, Jerrold [D-NY-10]
NADLER
D
2021-04-22
NY
B001296
2
Brendan
Rep. Boyle, Brendan F. [D-PA-2]
Boyle
F.
D
2021-04-22
PA
S001159
10
Marilyn
Rep. Strickland, Marilyn [D-WA-10]
Strickland
D
2021-04-22
WA
D000624
12
Debbie
Rep. Dingell, Debbie [D-MI-12]
Dingell
D
2021-04-22
MI
N000192
3
Marie
Rep. Newman, Marie [D-IL-3]
Newman
D
2021-04-22
IL
M001185
18
Sean
Rep. Maloney, Sean Patrick [D-NY-18]
Maloney
Patrick
D
2021-04-22
NY
J000306
17
Mondaire
Rep. Jones, Mondaire [D-NY-17]
Jones
D
2021-05-07
NY
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-22
2021-10-19
Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
House
Environmental Protection
2021-04-22
Read twice and referred to the Committee on Environment and Public Works.
CRS
Identical bill
PFAS Accountability Act of 2021
S
D000631
4
Madeleine
Rep. Dean, Madeleine [D-PA-4]
N
Dean
D
PA
Blood and blood diseases Civil actions and liability Environmental assessment, monitoring, research Environmental health Federal district courts Hazardous wastes and toxic substances Health care costs and insurance Health care coverage and access Health promotion and preventive care Manufacturing Medical research Medical tests and diagnostic methods Pollution liability
2021-04-22
Introduced in House
 <p><strong>PFAS Accountability Act of 2021</strong></p> <p>This bill provides a cause of action under the Toxic Substances Control Act for individuals or classes of individuals who were significantly exposed to perfluoroalkyl or polyfluoroalkyl substances, commonly referred to as PFAS. These substances are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing.</p> <p>Specifically, the bill provides a cause of action those who were significantly exposed to PFAS (or have reasonable grounds to believe they were exposed) against persons who engaged in any portion of a manufacturing process that created the PFAS and foresaw (or reasonably should have foreseen) the creation or use of PFAS would result in human exposure.</p> <p>The bill authorizes a court to award medical monitoring to claimants if (1) they have been significantly exposed to PFAS, (2) they have an increased risk of developing a disease associated with such exposure, (3) the increased risk provides a reasonable basis to conclude that periodic diagnostic medical examinations is necessary, and (4) the medical examinations are effective in detecting a disease associated with PFAS exposure.</p> <p>The bill establishes a presumption of significant exposure to PFAS if the claimant (1) provides medical results proving the presence of PFAS in the body, or (2) demonstrates the defendant's manufacturing process created the PFAS to which the claimant was exposed and the PFAS were released into one or more areas where the claimant would have been exposed for at least one year.<br> </p>
2022-01-21T15:38:34Z
00
2021-04-22T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2751ih/xml/BILLS-117hr2751ih.xml
PFAS Accountability Act of 2021
PFAS Accountability Act of 2021
Display Title
IH
Introduced in House
To amend the Toxic Substances Control Act to codify a Federal cause of action and a type of remedy available for individuals significantly exposed to per- and polyfluoroalkyl substances, to encourage research and accountability for irresponsible discharge of those substances, and for other purposes.
Official Title as Introduced
IH
Introduced in House
PFAS Accountability Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:48:38Z
2023-01-11T13:48:38Z
3.0.0
2021-04-22
Read twice and referred to the Committee on Environment and Public Works.
CRS
Identical bill
PFAS Accountability Act of 2021
S
2021-10-19
Constitution and Limited Government Subcommittee
hsju10
1
House committee actions
Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
Committee
2021-04-23
Environment, Manufacturing, and Critical Materials Subcommittee
hsif18
1
House committee actions
Referred to the Subcommittee on Environment and Climate Change.
Committee
H11100
2021-04-22
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-22
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-22
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-22
9
Library of Congress
Introduced in House
IntroReferral
D000631
4
Madeleine
Rep. Dean, Madeleine [D-PA-4]
N
Dean
D
PA
K000380
5
Daniel
Rep. Kildee, Daniel T. [D-MI-5]
Kildee
T.
D
2021-04-22
MI
T000481
13
Rashida
Rep. Tlaib, Rashida [D-MI-13]
Tlaib
D
2021-04-22
MI
N000002
10
JERROLD
Rep. Nadler, Jerrold [D-NY-10]
NADLER
D
2021-04-22
NY
B001296
2
Brendan
Rep. Boyle, Brendan F. [D-PA-2]
Boyle
F.
D
2021-04-22
PA
S001159
10
Marilyn
Rep. Strickland, Marilyn [D-WA-10]
Strickland
D
2021-04-22
WA
D000624
12
Debbie
Rep. Dingell, Debbie [D-MI-12]
Dingell
D
2021-04-22
MI
N000192
3
Marie
Rep. Newman, Marie [D-IL-3]
Newman
D
2021-04-22
IL
M001185
18
Sean
Rep. Maloney, Sean Patrick [D-NY-18]
Maloney
Patrick
D
2021-04-22
NY
J000306
17
Mondaire
Rep. Jones, Mondaire [D-NY-17]
Jones
D
2021-05-07
NY
Blood and blood diseases Civil actions and liability Environmental assessment, monitoring, research Environmental health Federal district courts Hazardous wastes and toxic substances Health care costs and insurance Health care coverage and access Health promotion and preventive care Manufacturing Medical research Medical tests and diagnostic methods Pollution liability
2021-04-22
Introduced in House
 <p><strong>PFAS Accountability Act of 2021</strong></p> <p>This bill provides a cause of action under the Toxic Substances Control Act for individuals or classes of individuals who were significantly exposed to perfluoroalkyl or polyfluoroalkyl substances, commonly referred to as PFAS. These substances are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing.</p> <p>Specifically, the bill provides a cause of action those who were significantly exposed to PFAS (or have reasonable grounds to believe they were exposed) against persons who engaged in any portion of a manufacturing process that created the PFAS and foresaw (or reasonably should have foreseen) the creation or use of PFAS would result in human exposure.</p> <p>The bill authorizes a court to award medical monitoring to claimants if (1) they have been significantly exposed to PFAS, (2) they have an increased risk of developing a disease associated with such exposure, (3) the increased risk provides a reasonable basis to conclude that periodic diagnostic medical examinations is necessary, and (4) the medical examinations are effective in detecting a disease associated with PFAS exposure.</p> <p>The bill establishes a presumption of significant exposure to PFAS if the claimant (1) provides medical results proving the presence of PFAS in the body, or (2) demonstrates the defendant's manufacturing process created the PFAS to which the claimant was exposed and the PFAS were released into one or more areas where the claimant would have been exposed for at least one year.<br> </p>
2022-01-21T15:38:34Z
00
PFAS Accountability Act of 2021
PFAS Accountability Act of 2021
Display Title
IH
Introduced in House
To amend the Toxic Substances Control Act to codify a Federal cause of action and a type of remedy available for individuals significantly exposed to per- and polyfluoroalkyl substances, to encourage research and accountability for irresponsible discharge of those substances, and for other purposes.
Official Title as Introduced
IH
Introduced in House
PFAS Accountability Act of 2021
Short Title(s) as Introduced
2021-10-19
Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.